With further research, the 2022 edition of WHO proposed that a few cases of FH-deficient renal cell carcinoma are eosinophilic low-grade forms, but the description is relatively brief, and most of these rare form of tumors have a relatively favorable prognosis (3). The gene discussed is FH; the disease is renal cell carcinoma.